Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals
Waltham, MA, August 4, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by…
Read Now
Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio
Waltham, MA, July 19, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more…
Read Now
Commerical Teams in the Life Sciences Need a Gradual, Stepwise Approach to Product Launches to Achieve Success, according to a New White Paper Available Now from Trinity Life Sciences
Waltham, MA, June 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that 62 percent of biopharma products that launched between September 2019 and December 2021 underperformed expectations, including 24 out of 28 non-rare, non-oncology products. According to a new white paper entitled Empowering the…
Read Now
Webinar Entitled “Reimagining Work Models in the Life Sciences: Implications for the Future of Work” Will be Held on June 23
Waltham, MA, June 21, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work. The study is the first of its kind for the life sciences industry as it provides objective data to help companies make informed…
Read Now
“Patient Centricity: Optimizing Integration throughout the Lifecycle” Available Now from Trinity Life Sciences
Waltham, MA, June 13, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out the complexities life sciences companies are grappling with as they pull the “idea” of patient centricity through to execution and measurable results. While the vision and goal of patient centricity are clear, the challenge is crafting concrete steps to integrate the patient voice throughout the product lifecycle and…
Read Now
Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a System In-House
Waltham, MA, June 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the launch of Government Pricing (GP) services within TGaS Advisors. The new services help pre-commercial and emerging life sciences companies develop their GP policies and methodologies and provide support for ongoing GP calculations. Because drug pricing in the U.S. remains at…
Read Now
Office Relocation in Gurgaon Creates Space for Growth and Innovation in the Asia-Pacific Region
Gurgaon, India, May 16, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the opening of its next-generation office space in Gurgaon, India. The opening of the new office is part of Trinity’s ongoing commitment to support development and innovation in the Asia-Pacific region.
Located near the “cyber hub of India,” the impressive new office boasts sleek contemporary design and state-of-the-art…
Read Now
Survey Reflects Trinity Employees Trust in Leadership and the Enthusiasm for Professional Growth and Opportunities
Waltham, MA, May 11, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has been named to Inc.’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May 17, 2022, and prominently featured on Inc.com, the list is the result of a comprehensive measurement of American companies that have excelled in creating exceptional workplaces and company culture.…
Read Now
New White Paper Entitled “Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR” Available from Trinity Life Sciences
Waltham, MA, May 10, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, explores the implications of significant evolution and growth in the U.S. Health Economics and Outcomes Research (HEOR) field over the last decade. Many changes have been driven by payers, regulators and clinicians who are increasingly looking to HEOR and Real-World Evidence…
Read Now
Seventy-Three Percent of Medical Affairs Leaders Rate the Overall Working Relationship with Commercial Leaders as Strong to Very Strong, According to a New TGaS Landscape Report from Trinity Life Sciences
Waltham, MA, April 25, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions released its latest TGaS Landscape report entitled, Commercial and Medical Affairs Leaders Landscape 2022. The report finds that in order to optimize the effectiveness between Commercial and Medical Affairs, a dynamic approach to…
Read Now
